Healthcare Global Enterprises · NSE: HCG · BSE: 539787

Q1 FY27 results · Apr–Jun 2026

Healthcare Global Enterprises reported revenue from operations of ₹695.10 crore (up 13.4% from Q1 FY26) and net profit of ₹16.46 crore (up 175.3% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.

Consolidated · ₹ crore
Item	Q1 FY27	Q1 FY26	YoY	Q4 FY26	QoQ
Revenue from operations	695.10	613.16	+13.4%	652.33	+6.6%
Other income	12.13	6.83	+77.6%	13.07	−7.2%
Total income	707.23	619.99	+14.1%	665.40	+6.3%
Profit before share of associates & JVs and tax	24.10	11.24	+114.4%	0.73	33x
Share of profit/(loss) of associates & JVs	0.93	0.68		0.52
Net profit for the period	16.46	5.98	+175.3%	4.04	+307.4%
Attributable to shareholders of the company	13.77	4.75	+189.9%	2.17	+534.6%
EPS, basic (₹)	0.92	0.34	+170.6%	0.15	+513.3%
Net margin (%)	2.4	1.0		0.6

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q1 FY27	Q1 FY26	YoY	Q4 FY26	QoQ
Revenue from operations	376.66	327.09	+15.2%	350.21	+7.6%
Other income	9.56	7.94	+20.4%	14.92	−35.9%
Total income	386.22	335.03	+15.3%	365.13	+5.8%
Profit before tax	7.48	5.24	+42.7%	(8.95)	Turned profit
Net profit for the period	5.58	3.45	+61.7%	1.53	+264.7%
EPS, basic (₹)	0.37	0.25	+48.0%	0.11	+236.4%
Net margin (%)	1.5	1.1		0.4

Consolidated

Filed with BSE: 06 Aug 2026, 19:30 IST
Board meeting: 06 Aug 2026
Period: 01 Apr 2026 to 30 Jun 2026
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 06 Aug 2026, 19:30 IST
Board meeting: 06 Aug 2026
Period: 01 Apr 2026 to 30 Jun 2026
Review status: Unaudited
Source: XBRL filing on BSE